{"id":"doi:10.1016/s0140-6736(21)00213-0","kind":"article","title":"Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","authors":["Melanie Jane Davies","Louise Færch","Ole Kleist Jeppesen","Arash Pakseresht","Sue D. Pedersen","Leigh Perreault","Julio Rosenstock","Iichiro Shimomura","Adie Viljoen","Thomas A. Wadden","Ildiko Lingvay"],"author_count":11,"year":2021,"published":"2021-03-01","venue":"The Lancet","cited_by":1419,"doi":"10.1016/s0140-6736(21)00213-0","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s0140-6736(21)00213-0","archive_url":"https://space-kitty.com/papers/doi:10.1016/s0140-6736(21)00213-0","updated":null,"pmid":"33667417","pmcid":null,"openalex_id":"W3133746780","pdf_url":null,"abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}